Anti-DGAT2 Antibody, clone 2H10 ZooMAb^® Rabbit Monoclonal

Quality Control Testing

Evaluated by Western Blotting in human liver tissue lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected DGAT2 in human liver tissue lysate.

Tested Applications

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected DGAT2 in PC3 cell lysates and DGAT2 Recombinant Protein.

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected DGAT2 in human liver tissue sections.

Affinity Binding Assay Analysis: The binding affinity of this antibody to DGAT2 peptide was at least ten thousand-fold (10,000X) higher than that obtained with the non-specific control peptide.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user

Clone 2H10 is a ZooMAb^® rabbit recombinant monoclonal antibody that detects DGAT2. It targets an epitope within 15 amino acids from the cytoplasmic domain of the protein.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Diacylglycerol O-acyltransferase 2 (UniProt: Q96PD7; also known as EC:2.3.1.20, Acyl-CoA retinol O-fatty-acyltransferase (ARAT; Retinol O-fatty-acyltransferase), Diglyceride acyltransferase 2) is encoded by the DGAT2 gene (Gene ID: 84649) in human. Diacylglycerol O-acyltransferase 2 (DGAT2) is an integral transmembrane protein, localized in the endoplasmic reticulum and on lipid droplets. It contains an N- and a C-terminal cytoplasmic domain (aa 1-69 and aa 113-388, respectively), two transmembrane domains (aa 78-88 and 93-112), and a lumenal region (aa 89-92). It plays a crucial role in lipid metabolism. DGAT2 catalyzes the final step in triglyceride synthesis, which involves the esterification of diacylglycerol with fatty acyl-CoA to form triglycerides. This enzymatic activity is important for the storage of dietary fats and the production of endogenous triglycerides. DGAT2 is primarily expressed in the liver and adipose tissue. DGAT2 has been implicated in the regulation of lipid homeostasis and energy balance and is considered a potential target for the development of therapeutic strategies against metabolic disorders such as obesity and dyslipidemia. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.

We are committed to bringing you greener alternative products, which adhere to one or more of the 12 Principles of Green Chemistry. This antibody is preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed, and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

KLH-conjugated linear peptide corresponding to 15 amino acids from the Cytoplasmic domain of human DGAT2.

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

Reconstitute lyophilized antibody pellet with 25μL of ultrapure water or Phosphate Buffered Saline (PBS). Please refer to our reconstitution protocol and the specific application guidance on the suggested starting dilutions and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany